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PG has been identified as a psychiatric 
disorder in its own right since 1980, 
and is included within the current DSM 
(DSM-IV TR; APA, 2000) as an Impulse 
Control Disorder. The recommendation 
to re-classify this disorder has been 
made as a result of the increasing 
body of literature which reveals a high 
degree of similarity between SUDS and 
PG in relation to diagnostic criteria, 
co-morbidities, biological bases and 
treatment. 
With regard to diagnosis, five 
of the DSM- IV TR (APA, 2000) 
diagnostic criteria for PG are based 
on SUDS criteria (i.e., interference in 
life functioning, tolerance, withdrawal, 
repeated unsuccessful attempts to 
quit & preoccupation with the drug / 
gambling: Petry, 2006; Potenza, 2006). 
There are high rates of co-morbidity 
between the two disorders, for example, 
lifetime prevalence rates of PG in 
SUDS populations are estimated at 14% 
(Shaffer, Hall & Van der Bilt, 1999), 
with point prevalence rates between 10-
13% (Cunningham-Williams,  Cottler, 
Compton, Spitznagel, & Ben-Abdallah, 
2000; Langenbucher, Bavly, Labouvie, 
Sanjuan, & Martin, 2001) compared 
to general population rates of 0.4-2% 
(Petry, Stinson, & Grant, 2005). In PG, 
70% present with alcohol use disorders 
and 30% with disorders involving 
another drug (Petry et al., 2005). In 
addition, co-occurring mood and anxiety 
disorders are a common characteristic 
of SUDS in community and inpatient 
populations (Adamson, Todd, Sellman, 
Huriwai, & Porter, 2006; Burns & 
Teeson, 2002; Goodwin, Fergusson, & 
Horwood, 2004; Merikangas, Mehta, & 
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The term addiction has been used to refer to impaired control over 
substance use for several centuries 
(Potenza, 2006) however, more recently 
there has been a shift toward using this 
term in the context of non-substance use 
related disorders, such as pathological 
gambling (PG). This stems from the 
observation that core components of 
addictive behaviour can be observed 
in a variety of behaviours which are 
not related to substance use such as 
PG, compulsive sex, shopping, and 
computer use (Griffiths, 2000; Potenza, 
2009). These core components include 
preoccupation with the behaviour, 
craving or appetitive urge to engage 
in the behaviour, diminished control 
over the compulsion to engage in 
the behaviour, repeated unsuccessful 
attempts to cut down or stop the 
behaviour, tolerance, withdrawal 
symptoms and continued engagement 
in the behaviour despite ongoing 
legal, social and health consequences 
(Grant, Potenza, Weinstein & Gorelick, 
2010; Griffiths, 2000; Potenza, 2009; 
Wareham & Potenza, 2010). In fact, it 
has been suggested that these disorders 
could be best described as ‘behavioural 
addictions’ (Holden, 2001; Petry, 2006). 
However, whether these ‘behavioural 
addictions’ should fall under diagnostic 
criteria for addictions, compulsive 
disorders or impulse control disorders 
is still being debated (Potenza, 2009).
The proposed changes to diagnostic 
criteria in the upcoming Diagnostic and 
Statistical Manual of Mental Disorders 
5th Edition include the renaming of the 
‘Substance-Related Disorders’ category 
to ‘Substance Use and Addictive 
Disorders’ to incorporate substance use 
disorders (SUDS) and non-substance 
addictions (specifically Gambling 
Disorder; APA, 2011; Petry, 2010). 
The term addiction has been used to refer to impaired control over substance 
use for several centuries however recently there has been a shift toward using 
this term in the context of non-substance use disorders, such as pathological 
gambling. A preliminary investigation was conducted in an attempt to clarify 
the most appropriate classification of ‘behavioural addictions’. Participants 
with alcohol dependence (AD, n = 24), pathological gambling (PG, n = 20) and 
compulsive buying disorder (CBD, n = 14) completed an Addictive Disorder 
Questionnaire (ADQ); the Symptom Checklist 90 Revised (SCL-90R); Barratt 
Impulsivity Scale II; and substance specific adaptations of the Yale-Brown 
Obsessive Compulsive Scale (Y-BOCS). Although the AD group reported 
more severe addiction symptoms and had higher levels of depression and 
anxiety, there were broad similarities across the three disorders in relation to 
cravings, dyscontrol, impulsivity and obsessions. Despite the small sample 
size and the different recruitment strategies used across the groups, the 
findings from this preliminary study provide support for broadening addiction 
diagnostic definitions to include non-substance related disorders which in 
turn may contribute to the development of more efficacious treatments.
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Molnar et al., 1998) and PGs (Crockford 
& el-Guebaly, 1998; el-Guebaly et al., 
2006; Kessler et al., 2008). 
Epidemiological studies suggest 
that 26-37% of those with alcohol 
dependence also had a lifetime history 
of mood disorder (with depression 
being the most common), whereas 32-
37% met lifetime criteria for an anxiety 
disorder (Jane-Llopis & Matytsina, 
2006; Merikangas et al., 1998; Robins 
& Regier, 1991). Similarly, in PGs, 
epidemiological studies report a lifetime 
prevalence of over 50% for mood 
disorders and 40% for anxiety disorders 
(Kessler et al., 2008). Both are highly 
prevalent in those seeking treatment 
for PG (el-Guebaly et al., 2006; Kim, 
Grant, Eckert, Faris & Hartman, 2006) 
with up to 75% meeting criteria for 
a major depressive disorder and high 
rates of anxiety disorders (Crockford & 
el-Guebaly, 1998). 
In addition to similarities in 
diagnostic criteria and co-morbidities, 
research indicates similarities in the 
neurocognitive aspects of SUDS 
and PG, particularly in relation to 
impaired impulse control (Verdejo-
Garcίa, Lawrence & Clark, 2008). 
Several studies suggest deficits in 
executive function in PGs (e.g., Rugle & 
Melamed, 1993) and SUDS (Lawrence, 
Luty, Bogdan, Sahakian, & Clark, 2009) 
and similar neurotransmitter systems 
are implicated in both disorders (see 
Potenza 2006 for review). Genetic 
components also appear to play a key 
role in both disorders, with increased 
risk in those with a first degree relative 
with the same disorder (McGue, 1999; 
Volberg & Steadman, 1989) and possibly 
a shared genetic vulnerability (Slutske 
et al., 2000). However, as noted by 
Aasved (2004), the influence of early 
learning experiences in the development 
of addiction, must also be considered 
in these familial studies. In terms of 
treatment, many of the current PG 
treatments have been adapted from those 
used in SUDS (e.g., Relapse Prevention, 
Motivational Enhancement Therapy, 
and Gamblers Anonymous: Petry, 2006; 
Potenza, 2006; Wareham & Potenza, 
2010), although further research on the 
efficacy of treatment is needed.
Overall, there are clear similarities 
between SUDS and PG and extensive 
evidence to support the inclusion of 
PG as an addictive disorder. However, 
as yet it is unclear if other ‘behavioural 
addictions’ are to be included in the 
DSM-V, and if they are, how they will 
be classified. Other proposed changes 
to the DSM-V include the creation 
of a ‘Disruptive, Impulse Control 
and Conduct Disorders’ category 
(incorporating oppositional defiant 
disorder, pyromania, kleptomania, 
conduct disorder and intermittent 
explosive disorder) and an ‘Obsessive-
Compulsive and Related Disorders’ 
category (incorporating obsessive 
compulsive disorder, body dysmorphic 
disorder, hoarding, hair pulling and 
skin picking), both of which could 
incorporate ‘behavioural addictions’ 
(APA, 2011).
Based on the groundwork made by 
PG research, there is growing support for 
academic and clinical acknowledgment 
of other ‘behavioural addictions’, 
including: internet use (Yellowlees 
& Marks, 2007); online multiplayer 
role-play games (Charlton & Danforth, 
2007); compulsive sexual behavior 
(Schneider, Sealy, Montgomery & Irons, 
2005); over eating and eating disorders 
(Jordanby, Pineda, & Gold, 2005) and 
a publicly perceived ‘novel’ addiction 
- compulsive buying disorder (CBD). 
P r o b l e m a t i c  s h o p p i n g 
symptomology has been evident for 
over 90 years, and was first termed 
‘oniomania’ by German psychiatrist 
Emil Kraepelin (Black, 2001). In the 
late 1990’s the first epidemiological 
studies were conducted to determine 
the prevalence of CBD, even though 
some researchers still question whether 
this disorder should be categorised as a 
mental illness, or if it would be better 
viewed from a moral or legal perspective 
(Hollander & Allen, 2006). CBD is 
not specifically included in the current 
DSM-IV TR, but those who present 
with symptoms would most likely be 
diagnosed under the category “Disorder 
of Impulse control not otherwise 
specified” (Black, 2001). Similar to 
SUDS and PG, CBD is characterized by 
salience (preoccupations and cravings 
related to shopping), dyscontrol (urges 
or compulsions to shop and purchase), 
and associated adverse social and legal 
consequences (Black, 2001, 2007; 
Faber & O’Guinn, 1992). The repeated 
episodes of unnecessary spending are 
often triggered by negative mood, which 
is improved by buying (Black, 2007; 
Clark & Calleja, 2008). Epidemiological 
studies report a point prevalence of CBD 
of 5.8% (Koran, Chuong, Bullock, & 
Smith, 2006), with similar rates in males 
and females, however clinical studies 
suggest that 80-95% of those seeking 
treatment were female (Schlosser, 
Black, Repertinger, & Freet, 1994), 
possibly due to the greater willingness 
of women to seek help.
As with SUDS and PG, psychiatric 
comorbidity is common in compulsive 
shopping populations, including 
mood (21-100%); anxiety (41-80%); 
substance use (21-46%); eating; (8-
35%) personality (60%); and impulse 
control disorders (21-40%: see Black, 
2007; Christenson, Faber, & de Zwaan 
et al., 1994; Dell’Osso, Allen, Altamura, 
Buoli, & Hollander, 2008; Monahan, 
Black, & Gabel, 1996). Given the 
symptoms of CBD, it is surprising that 
there does not appear to be a strong link 
with obsessive compulsive spectrum 
disorders. Frost, Sketee and Williams 
(2002) suggest that the link between 
CBD and obsessive –compulsive 
disorder may be mediated by hoarding 
behavior because both groups become 
preoccupied with hunting for particular 
goods (Lejoyeux & Weinstein, 2010). 
Furthermore, studies suggest that over 
60% of compulsive hoarders also met 
criteria for compulsive buying (Frost, 
Tolin, Steketee, Fitch & Selbo-Bruns, 
2009).
As yet, little information is available 
in relation to the neurochemical basis of 
CBD. Studies evaluating the efficacy 
of antidepressants (serotonin re-uptake 
inhibitors) in treating CBD have 
produced mixed results (Black, 2007; 
Grant & Potenza, 2004), suggesting that 
serotonin abnormalities may not be a 
core feature of this disorder. However, 
there is evidence that genetics may 
play a role in CBD, with reports of 
high rates of major depression, SUDS 
and anxiety disorders in first degree 
relatives (McElroy, Keck, Pope, Smith, 
& Strakowski, 1994). Genetics studies 
have failed to find an association 
between two serotonin transporter 
polymorphisms and CBD (Devor, 
Magee, Dill-Devor, Gabel, & Black., 
1999), but an association was found 
with the dopamine (D1) receptor gene 
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(Comings, 1998). Currently there is no 
standard treatment for CBD, but the 
most successful appear to be group 
cognitive behaviour therapy treatments 
(Mitchell et al., 2006: Mueller et al., 
2008) however further research is 
needed to determine the most efficacious 
treatment for this disorder.
Returning to the classification of 
CBD there are three options: to classify 
it as 1) an addictive disorder; 2) an 
obsessive compulsive disorder or 3) an 
impulse control disorder. From the brief 
summary of CBD, it is clear that it has 
features in common with disorders in 
each of these categories. With regard 
to viewing CBD as an addiction, most 
clinical samples with symptoms of CBD 
would probably meet these criteria. In 
particular, they are preoccupied with 
buying items, they have irresistible 
urges and impulses to buy which are 
ameliorated by purchasing, and they 
continue to spend despite problems 
caused by the behaviour (Black, 2001; 
2007; Dell’Osso et al., 2008). Similarities 
with obsessive compulsive disorders 
(OCD) relate to persistent and intrusive 
thoughts about shopping and buying. 
There are however some important 
differences: the behaviours associated 
with OCD are often unpleasant and 
conducted to relieve anxiety, not for 
pleasure; although buying in CBD is 
conducted to relieve depressed mood, 
the act itself is also pleasurable and 
rewarding. Finally, impulse control 
disorders are characterised by the failure 
to resist an impulse to perform an act 
that may harm themselves or others. 
Furthermore for many impulse control 
disorders, committing the act leads to 
pleasure and a decrease in arousal (APA, 
2000). These descriptors show many 
similarities to the symptoms of CBD.
This study was conducted to 
identify, explore and understand the 
common cognitive and behavioural 
phenomena that occur within SUDS and 
non-substance addictions (PG & CBD), 
in order to provide some preliminary 
data  regarding the  appropria te 
classification of these disorders. The 
way these disorders are classified has 
widespread implications. For those 
with the disorder, it will affect how 
they are ‘labelled’ and perceived by 
others; for researchers it will clarify 
the most appropriate literature to draw 
on to develop new strategies for the 
treatment and prevention of these 
disorders. Furthermore, the recognition 
of ‘behavioural addictions’ offers 
researchers the opportunity to study 
addiction without the confounding 
effects of drug ingestion, which has the 
potential to improve our understanding 
of the core aspects of addiction (Petry, 
2007, 2010; Phillips, 2006).
The study set out to provide 
preliminary data to: 1) describe the 
common characteristics of alcohol 
dependence, pathological gambling and 
compulsive buying disorder; 2) compare 
the level of anxiety and mood disorders 
across the three groups and; 3) evaluate 
the relationship between mood and 
anxiety, and the severity of the disorder.
Method
The study received approval from 
the Department of Psychology Ethics 
Committee, University of Waikato.
Participants
A total of 64 participants were 
recruited. 24 participants were recruited 
in the AD(Alcohol Dependent) group; 
20 in the PG(Pathological Gambling) 
group and 20 in the CBD(Compulsive 
Buying Disorder) group. As the 
AD and PG group were recruited 
via service providers and access to 
services usually requires a confirmed 
diagnosis, participant self-report were 
used to confirm their diagnosis and 
thus eligibility to participate in the 
study. The CBD group responded to 
advertising, which asked for individuals 
who found it difficult to control their 
buying, leading to conflict and problems 
with their relationships and general 
wellbeing. Each potential participant 
was asked to complete the Compulsive 
Buying Screen (CBS; Faber & O’Guinn, 
1992) to ensure they met the criteria 
for CBD (total score < -1.34). Of the 
20 volunteers for the CBD group, 14 
participants met criteria and only their 
data was used in subsequent analyses.
Participants in the AD group were 
between 19-60 years of age (mean = 
34.13, SD = 11.06), 71% (n = 17) were 
male. A third of the participants were 
employed (n = 8), 62.5% (n = 15) were 
unemployed and 1 was a student. The 
majority of the AD participants (62.5%, 
n = 15) identified as New Zealand 
European / Pakeha; 21% (n = 5) as 
Māori, and 1 each as Pacific Island, NZ 
German, English, and American.
The PG group was comprised of 20 
participants aged 25-59 years (mean = 
38.3, SD = 10.35), of whom over half 
were male (70%, n = 14). Three quarters 
of the sample were employed (75%, n = 
15), with 25% (n = 5) unemployed. Over 
half of the PG group self-identified as 
New Zealand European/Pakeha (55%, n 
= 11), 8 participants (40%) identified as 
Māori and 1 as Samoan/Chinese. 
The CBD group (n = 14) was made 
up entirely of females, aged between 
19-54 years (mean= 33.6, SD= 11.60). 
Ten (71.4%) were employed and 4 
(28.6%) were unemployed. Ten of 
the participants (71.4%) were of New 
Zealand European / Pakeha descent, 
2 (14.3%) were of Māori descent, and 
1 each of European/Māori and Pacific 
Island descent.
Measures
A study specific questionnaire was 
developed which asked participants 
to report standard demographic 
information (i.e., age, gender, ethnicity, 
employment status) and any diagnosed 
mental illnesses and/or addictions. 
The Compulsive Buying Scale 
(CBS; Faber & O’Guinn, 1992) was 
used to identify compulsive buyers. 
The CBS is a clinically valid and 
reliable (Cronbach’s alpha = .70; Clark 
& Calleja, 2008) instrument which 
has been extensively used to identify 
the rate and prevalence of CBD (e.g., 
Faber & Christenson, 1996; Koran et 
al., 2003; Mueller et al., 2010; Schlosser 
et al., 1994). The scale consists of 
seven statements representing specific 
behaviours and feelings related to 
compulsive buying. Items are rated on a 
5 point Likert rating scale (1 = strongly 
agree / very often to 5 = strongly 
disagree /never). CBS total scores are 
calculated by entering the scores into a 
regression equation (CBS total = -9.69 + 
(Qla x .33) + (Q2a x .34) + (Q2b x .50) + 
(Q2c x .47) + (Q2d x .33) + (Q2e x .38) 
+ (Q2f x .31). Lower scores on the scale 
represent higher levels of compulsive 
buying. Faber and O’Guinn (1992) 
suggested a cut off score (-1.34), two 
standard deviations below the general 
population mean. 
In order to compare symptoms across 
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the disorders, the authors developed an 
Addictive Disorders Questionnaire 
(ADQ), based on the diagnostic criteria 
for substance dependence from the 
DSM-IV (APA, 2000) and ICD-10 
(World Health Organization, 2007). 
Based on recommendations which 
sought to improve the accuracy of 
substance diagnostic criteria (Budney, 
2006; Budney, Radonovich, Higgins, 
& Wong, 1998; Hughes, 2006; Nelson, 
Rehm, Ustun, Grant & Cahtterji, 1999; 
Swift, Hall & Teesson, 2001), questions 
were developed that were specific to the 
substance (i.e., alcohol) or activity (i.e., 
gambling or shopping) and descriptors 
were added to the criteria for withdrawal 
to encompass both the physiological 
and emotional aspects of withdrawal 
(Budney, 2006; Schmitz, 2005). The 
questionnaire consisted of 11 items 
which required a yes/no response. The 
questionnaire was scored by summing 
the positively endorsed items. A score 
of > 3 was deemed to be indicative of 
dependence, based on the diagnostic 
criteria utilised in the DSM-IV TR 
(APA, 2000). 
Obsessions and compulsions 
were assessed using the Yale-Brown 
Obsessive-Compulsive Scale (Y-BOCS; 
Goodman, Price, Rasmussen et al., 
1989), which has been adapted for 
use with AD, (Y-BOCS-HD; Modell, 
Glaser, Mountz, Schaltz, & Cyr, 1992) 
PG (BOCS-PG; Pallanti, DeCaria, 
Grant, Urpe, & Hollander, 2005) 
and CBD populations (Y-BOCS-SV; 
Monahan, Black, & Gabel, 1996). The 
Y-BOCS is a widely used measure of 
obsessions, compulsions, and severity 
in Obsessive Compulsive Disorder 
(OCD). The measure is unique in that 
it focuses on the person’s experience 
of the symptoms rather than on the 
content of persons’ symptoms. All three 
versions of the Y-BOCS are reported 
to have good internal consistency 
and validity (e.g., Connor, Feeny & 
Young, 2005; Koran, Chuong, Bullock 
& Smith, 2003; Pallanti, DeCaria, 
Grant, Urpe & Hollander, 2005). Each 
version of the questionnaire consists of 
ten items which are rated from 0 (no 
symptoms) to 4 (extreme symptoms). 
The Y-BOCS yields obsessive (items 
1 – 5) and compulsive (items 6 – 10) 
subscales scores as well as a total scale 
score. Higher scores on the Y-BOCS 
sub-scales and total score reflects 
greater symptom severity and poorer 
functioning (Federoff, Sobell, Agrawal, 
& Gavin, 1999; Modell et al, 1992).
Impulsivity was assessed using the 
Barratt Impulsiveness Scale (BIS–II: 
Barratt & Stanford, 2000) which has been 
used extensively in these populations: 
AD (Dom, Wilde, Hulstijn, Brink & 
Sabbe, 2006); PG (Fuentes, Tavares, 
Artes, & Gorenstein, 2006; Nower & 
Blaszczynski, 2006); and CBD (Clark 
& Calleja, 2008; Mueller, Mueller et al., 
2007; Mueller et al., 2008). The BIS-II is 
a 28 item Likert scale rated from Rarely/
Never (0), to Almost always/always (4). 
Higher scores indicate a higher level of 
impulsiveness and the total score was 
the measure of interest.
The anxiety and depression 
subscales of the Symptom Checklist-
90-Revised (SCL-90-R: Derogatis, 
1994) were used to screen participants 
for co-morbid mood disorders. The 
SCL-90-R has excellent reliability and 
validity, has been used in a New Zealand 
context (Barker-Collo, 2003) and with 
various clinical populations, including 
those with AD (Kiefer et al., 2005; 
Lucht, Jahn, Barnow, & Freyberger, 
2002), PG (Petry, 2002) and CBD 
(Mueller, Mueller et al., 2007; Mueller 
et al., 2008; Rodriguez-Villarino, 
Lez-Lorenzo, Fernandez-Gonzalez, 
Lameras-Fernandez & Foltz, 2008). 
Each item describes a problem which 
the respondent rates for how much that 
problem has distressed or bothered 
them in the past week. Questions are 
rated on a 5 point scale from not at all 
(0) to extremely distressing (4). Scale 
scores are computed by summing 
the values of each contributing item 
completed, divided by the total number 
of items completed. The depression 
scale consists of 13 items, while the 
anxiety scale consists of 10 items. Raw 
scores were converted to T scores using 
normative data from the manual where 
necessary.
Procedure
Participants with AD and PG were 
recruited via posters and presentations 
at residential alcohol and drug treatment 
centres and out-patient gambling 
treatment services in three New Zealand 
cities (Auckland, Hamilton & Nelson). 
Compulsive Buyers were recruited via 
publicity in the local press, advertising 
in 41 budget advisory services (across 
NZ), and advertising on internet online 
shopping and auction sites. Participants 
expressing an interest in taking part 
in the study were posted or emailed 
a detailed information sheet which 
outlined the research procedure, the 
rights of the participant and the goals 
of the research. 
Participants who agreed to take part 
were given the option of completing the 
questionnaires in a face-to-face meeting 
with the researcher (at a mutually 
convenient location), receiving and 
returning the questionnaires by post, or 
completing them online and submitting 
their responses electronically. Those 
meeting the researcher in person were 
asked to sign a consent form. For all 
other participants, the information sheet 
explained that consent was deemed to 
have been given if the questionnaires 
were completed and returned. The 
questionnaires took approximately 25 
minutes to complete.
The majority of the AD participants 
and around half of the PG participants 
completed the questionnaire with the 
researcher. The other PG participants 
returned the questionnaires by post and 
the majority of the CBD group completed 
the questionnaires electronically. Once 
the questionnaires were completed, 
participants were offered the option 
of being debriefed by the researcher. 
Participants were also offered a ‘koha’ 
(gift) of a $10 supermarket or ‘The 
Warehouse’ voucher as a thank-you for 
participating in the research. Vouchers 
were posted to those who completed 
questionnaires by post or email, and 
given directly to those who completed 
the questionnaires with the researcher.
With regard to cultural competency, 
the researcher collecting the data (AM) 
is of Māori and Scottish decent, and 
has a 5 year history of working cross 
culturally within the addiction field. 
As part of this study the researcher 
also undertook clinical and cultural 
supervision. This was undertaken to 
ensure tikanga (practices and values) 
and cultural safety (for both participant 
and researcher) was maintained when 
working with Māori participants, and 
when formally meeting staff at treatment 
agencies.
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Data analysis
Raw data was entered into SPSS 
version 11.0 for Windows. Measures 
were scored according to published 
instructions and missing data were 
handled in accordance with the published 
scoring directions for each measure. 
Results
The f i rs t  a im of  the  s tudy 
related to the identification of shared 
characteristics of AD, PG and CBD. 
The ADQ is based on AD diagnostic 
criteria in the DSM-IV and the ICD-10 
and thus provides a means of comparing 
symptoms and their prevalence across 
the three groups. As the ADQ was 
developed specifically for this study, 
initial analyses were undertaken to 
examine the reliability and validity 
of the scale. The internal reliability 
of the ADQ was good (Cronbach’s 
alpha = .71), and ADQ scores showed 
a significant positive correlation with 
the YBOCS, an established measures 
of symptom severity (r = .61, n = 58, p 
<.001). Given these findings, scores on 
the ADQ were deemed suitable for use 
in subsequent analyses.
The first analysis utilised the 
standard DSM-IV AD diagnostic criteria 
of endorsement of 3 or more items. 
Analyses indicated that all participants 
met this cut-off (range of endorsed items 
for total sample 3 (min) to 11 (max). 
Furthermore, all items were endorsed 
by participants from each group. Table1 
summarises the number of participants 
in each group who endorsed each 
item of the ADQ. Chi-square analyses 
were used to identify differences in 
endorsement rate across the groups. 
Participants in each of the three groups 
were similar in their endorsement of 
items relating to craving (item 4) and 
dyscontrol (items 9 & 10). In terms of 
differences, the AD group showed a 
significantly higher rate of endorsement 
across all items, with lower rates shown 
by the PG and CBD groups. Items 
relating to tolerance (items 1 & 2) and 
the physical/ emotional consequences 
(item 8) of their disorder were endorsed 
significantly more frequently by the 
AD and PG groups compared to the 
CBD group. The AD group ‘lost’ more 
time (items 5 & 6) as a result of their 
disorder when compared to the PG and 
CBD groups. A significantly greater 
proportion of AD and CBD participants 
reported the activity as having physical/
mood improvement effects compared 
to the PG participants (item 3). Finally, 
a significantly higher proportion of the 
AD and PG groups had previously tried 
to quit compared to those in the CBD 
group.
To examine differences across the 
three disorders, a series of one-way 
analysis of variance (ANOVAs) were 
conducted to compare scores on the 
YBOCS and BIS (see Table 2). Where 
the overall ANOVA was significant, 
post-hoc tests were conducted using 
a Bonferroni correction. Analyses 
revealed that there were significant 
differences between the groups in 
relation to the YBOCS total score and 
the YBOCS compulsion subscale. This 
was explained by the AD participants 
obtaining significantly higher scores 
compared to the PG and CBD groups 
(p < .05).
To compare the levels of anxiety 
and depression in AD, PG and CBD, the 
raw SCL-90R scores were transformed 
to T scores based on gender specific 
general population norms. As well 
as calculating the mean T scores for 
each group, the number of participants 
within the average (50-84th percentile), 
above average (84-98th percentile) and 
high (>98th percentile) range were 
calculated. These scores are summarized 
in Table 3. Overall, the T scores for 
depression and anxiety were highest 
for the AD group, followed by the PGs 
and then those with CBD. One-way 
ANOVAs were conducted to compare 
the depression and anxiety T scores 
across the three groups. Analyses 
revealed significant differences across 
the groups in relation to depression, 
F(2,55) = 4.32, p = .02, η2 = .14, and 
anxiety, F(2,55) = 3.83, p = .03, η2 = 
.12. Post-hoc tests revealed that scores 
in the AD group were significantly 
higher compared to the CBD group for 
depression (p = .02) and anxiety (p = 
.03). Focusing on the severity levels 
of anxiety and depression, the AD and 
PG group had a greater proportion of 
participants experiencing more severe 
levels of anxiety and depression (Table 
3).
To examine the relationship 
between mood and the severity of 
the disorder, a series of Pearson’s 
correlations were conducted between 
symptoms endorsed on the ADQ, the 
YBOCS totals scores and the SCL-90R 
depression and anxiety scores (see 
Table 4). For the sample overall, there 
were significant positive correlations 
between the ADQ, the YBOCS and the 
SCL-90R depression and anxiety scores, 
suggesting that as addiction severity 
increases, symptoms of depression and 
anxiety increase. Correlations were 
also conducted separately for each 
group because the AD group obtained 
Scale AD (n=24)
Mean (SD)
PG (n=20)
Mean (SD)
CBD (n= 14)
Mean (SD)
ANOVA
BIS Total 73.9 (12.7) 70.3 (10.8) 76.1 (7.9) F (2,55) = 1.2, p = .30, η2 = .05
YBOCS Total 22.5 (7.7)† 17.0 (9.8) 16.3 (6.2) F (2,55) = 3.6, p = .03, η2 = .11*
YBOCS- Obsession 9.9 (4.1) 8.8 (4.8) 8.1 (3.2) F (2,55) = 0.90, p = .41, η2 = .03
YBOCS- Compulsion 12.6 (4.2) † 8.3 (5.6) 8.1 (3.4) F (2,55) = 6.6, p = .003, η2 = .19*
Table 2. The scores obtained by Alcohol Dependent (AD) Pathological Gambling (PG) and Compulsive Buying Disorder 
(CBD) participants in relation to impulsivity, obsessions and compulsions. 
* = p<.05; † = p<.05, †† = p<.01 compared to PG and CBD; η2 = eta squared, effect size; AD = alcohol dependence; PG 
= pathological gambling; CBD = compulsive buying disorder; BIS = Barrett Impulsiveness Scale; Y-BOCS = Yale Brown 
Obsessive Compulsive Scale
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significantly higher scores on the ADQ, 
YBOCS, and SCL90R depression and 
anxiety scales compared to the PG or 
CBD groups. For the AD group, YBOCS 
scores showed a significant positive 
correlation with depression and anxiety 
scores however, for the PG group only 
the ADQ showed a significant positive 
correlation with anxiety. No statistically 
significant correlations between these 
scales were observed for the CBD 
group. 
Together these findings suggest 
some similarities across the three 
disorders, particularly in relation to 
craving, dyscontrol, obsessions and 
levels of impulsivity. Differences 
between the groups were also apparent. 
Overall, the AD group had the greatest 
addiction severity (highest ADQ & 
YBOCS scores) and the highest levels of 
depression and anxiety. Fewer members 
of the CBD group had problems with 
tolerance or distress relating to their 
disorder compared to those with AD or 
PG, while fewer participants with PG 
reported physical or mood improvement 
effects relating to the behaviour. For the 
group overall, poor mood was related to 
increased addiction severity, however 
this was confounded by the high number 
of AD participants obtaining high scores 
on the ADQ and mood scales.
Discussion
The aims of this study were to 
conduct a preliminary investigation to 
describe the common characteristics of 
AD, PG and CBD; examine the levels 
of anxiety and depression disorders 
across the three groups and; evaluate the 
relationship between mood and anxiety, 
and the severity of the disorder.
With regard to the first study 
aim, the patterns of endorsement of 
diagnostic criteria in the ADQ indicate 
that the three common categories of 
addiction phenomenology (symptoms) 
of physiology, dyscontrol and salience 
were endorsed across the three groups. 
Despite some individual items being 
responded to differently across groups 
(e.g., the items related to tolerance were 
endorsed by fewer CBD participants) 
other items showed similar levels of 
endorsement among the groups. These 
results support earlier findings by 
Budney et al., (1998) and Stephens, 
Babor, Kadden & Miller, (2002) who 
found broad similarities in the types and 
number of DSM-IV symptoms endorsed 
across different drug addictions (i.e., 
cannabis versus cocaine; American 
Psychiatric Association, 2000). Thus, 
these preliminary findings provide 
support for the presence of AD 
addiction criteria (phenomena) across 
two behavioural addictions - PG and 
CBD. The use of more comprehensive 
description and representation of 
addiction phenomenology (i.e., re-
wording of withdrawal to include 
emotional aspects, and referring to the 
specific addiction in the ADQ) supports 
previous arguments for the broadening 
of addiction diagnostic terminology, 
in order to represent the psychological 
and physiological representation of each 
phenomena, rather than drug specific 
representations (Budney, 2006; Hughes, 
2006). This also provides some support 
for arguments for a unidimensional 
addiction construct, in which current 
substance addiction diagnostic criteria 
are appropriate for use within non-
substance addictions (Budney, 2006; 
Goodman, 1990; Petry, 2007).
With regard to other aspects of 
addiction, there were no significant 
differences in impulsivity across the 
three addiction groups. However, all 
groups met proposed cut-off scores for 
high levels of impulsivity (> 60; Ettelt, 
Ruhrmann, & Barnow et al., 2006; 
Preuss, Rujescu, & Giegling et al., 
2003). The AD sample in the current 
study obtained higher impulsivity scores 
compared to those reported by others 
(Bayle, Caci, Millet, Richa, Olie, 2003; 
Dom et al., 2006). In contrast the PG and 
AD (n = 24) PG (n = 20) CBD (n = 14)
SCL-90R Depression T score 71.3 (9.7) † 69.4 (10.4) 61.2 (11.5)
 50-84th percentile, n (%) 3 (12.5) 3 (15.0) 5 (35.7)
 84 - 98 percentile, n (%) 6 (25.0) 5 (25.0) 6 (42.9)
 > 98 percentile, n (%) 15 (62.5) 12 (60.0) 3 (21.4)
SCL-90R Anxiety T score 70.9 (8.0) † 65.3 (14.3) 60.4 (12.3)
 50-84th percentile n (%) 2 (8.3) 7 (35.0) 6 (42.9)
 84 - 98 percentile n (%) 10 (41.7) 6 (30.0) 6 (42.9)
 > 98 percentile, n (%) 12 (50.0) 7 (35.0) 2 (14.3)
Table 3. Mean levels of depression and anxiety and the number of participants in each severity category across the three 
groups. Data are presented as mean (SD) or n (%).
† p<.05 compared to CBD group from Bonferroni corrected post-hoc test. AD = alcohol dependence; PG = pathological 
gambling; CBD = compulsive buying disorder; SCL-90R = Symptom Checklist 90 Revised
AD (n = 24) PG (n = 20) CBD (n = 14) Overall (n = 58)
ADQ YBOCS ADQ YBOCS ADQ YBOCS ADQ YBOCS
SCL-90R depression .22 .49* .43 .38 .36 .03 .35** .37**
SCL-90R anxiety .09 .54** .45* .42 .38 .16 .37** .46**
* = p<.05, ** = p <.01. ADQ = Addictive Disorder Questionnaire; Y-BOCS = Yale Brown Obsessive Compulsive Scale; SCL-
90R = Symptom Checklist 90 Revised
Table 4. Pearson’s Correlations between disorder severity and mood
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CBD group scores were somewhat lower 
than expected (Fuentes et al., 2006; 
Mueller, Mitchell et al., 2007). Previous 
studies suggested that impulsivity 
was related to more severe addiction 
(Glantz, 1999; Glantz & Pickens, 1992), 
however, the current findings found 
similar level of impulsivity across the 
three groups, even though the AD group 
showed a significantly higher addiction 
severity. One possible explanation 
is that impulsivity may be related to 
specific aspects of addiction, such as 
compulsions, rather than addiction 
severity per se. 
With regard to other aspects of 
addiction, the AD group obtained 
higher compulsion scores compared 
to the PG and CBD groups. However 
overall, the YBOCs scores for the AD 
(Modell et al., 1992; Ilhan, Demirbas 
& Dogan, 2006) and PG groups were 
similar to previous findings (Grant et 
al., 2007) but the CBD group obtained 
much lower scores (Mitchell et al., 
2006; Mueller et al., 2007). Taken 
together, these finding suggest that the 
characteristics of the AD and PG groups 
were similar to those in other studies 
however the low YBOCS scores for 
the CBD group suggest that this group 
had less severe symptomatology. This 
is probably a result of differences in 
sample recruitment, which is a clear 
limitation of the current study. The 
majority of the AD group were residents 
in an alcohol and drug residential 
treatment programme, whereas the 
PG group participants were either in 
support groups or outpatient treatment. 
In contrast, the compulsive shoppers 
were predominantly from the general 
public, and not engaged in any treatment 
service, as there is no treatment agency 
for CBD. Nonetheless there were clear 
similarities in addiction phenomenology 
across the three groups.
Focusing on mood and anxiety 
disorders, the AD group obtained 
significantly higher scores for depression 
and anxiety compared to those with 
CBD. Furthermore, the majority of 
AD and PG participants obtained 
scores on the depression scale which 
placed them above the 98th percentile. 
A similar pattern was observed for the 
anxiety scores. The high prevalence 
and severity of depression and anxiety 
in the PG and AD groups suggest that 
these mood disorders are related to the 
severity of the addiction. For example 
it is possible that both depression and 
anxiety are related to failed attempts to 
restrict addiction behaviour, which has 
been cited in the literature as leading to 
‘secondary emotions’ such as profound 
guilt and dysphoria (Black, 2001; 
McElroy, Keck, Pope et al. 1994). In 
keeping with this, findings also indicated 
that depression and anxiety worsened as 
addiction severity increased, however 
this was most apparent in the AD 
group, with the more severe addiction. 
The high proportion of AD participants 
with scores over the 98th percentile 
on the SCL-90R suggests that further 
research to investigate the current use 
and suitableness of screening measures 
for identifying comorbid psychiatric 
issues within addiction services would 
be warranted. This is supported by a 
recent study of coexisting psychiatric 
disorders in New Zealand in which 
Adamson et al., (2006) identified that 
psychiatric disorders in alcohol and drug 
addiction populations were “ the rule 
and not the exception” (p.169), and that 
services need to be capable of screening 
for psychiatric disorders within the 
comprehensive assessment of addiction. 
There were clear limitations 
associated with current study. As 
previously mentioned, the number of 
participants in each group was relatively 
small and the three groups (AD, PG & 
CBD) were recruited from an inpatients 
setting, an outpatient / support group 
setting and through advertisement in 
the general public respectively. Thus, 
as well as having different ‘addictions’ 
of varying degrees of severity, the three 
groups would undoubtedly also differ 
in their level of motivation for change. 
In addition to this, addiction severity 
was assessed using a questionnaire 
developed by the authors for this study. 
Consideration was given to adapting 
one of the existing addiction severity 
measures (with known psychometric 
properties) however extensive changes 
would have been required, which may 
have changed the validity and reliability 
of the scale. Therefore, the authors 
felt that a questionnaire specifically 
designed for this study, based on current 
diagnostic criteria, would be most 
suitable.
In spite of these limitations, 
findings from the current study provide 
preliminary evidence for similarities 
across these three disorders, and it is 
therefore hard to justify CBD as an 
impulse control disorder (impulsivity 
scores were similar across the three 
groups) or an obsessive compulsive 
disorder (the AD group obtained the 
same YBOCS score). It is also evident 
that CBD has more in common with 
PG than AD, which may highlight the 
role of substance specific addiction 
phenomenology, although this may 
be related to the lower severity of the 
PG and CBD groups. The appropriate 
classification of CBD is important when 
considering treatment approaches, as 
treatments for impulse control disorders 
emphasise exposure and response 
prevention (Grant, Potenza, Weinstein 
& Gorelick, 2010), whereas behavioral 
addictions such as PG respond well to 
established SUDS treatment approaches 
such as motivational enhancement, 
cognitive behavioural therapies, and 
12-step self-help approaches (Grant, 
Potenza, Weinstein & Gorelick, 2010; 
see Pallesen, Mitsem, Kvale, Johnsen 
& Molde, 2005 for review). 
The development of common 
addiction phenomenology raises several 
positive clinical applications. With 
increased acceptance that addiction is 
more than physiological phenomena 
(i.e. ,  withdrawal and tolerance) 
attention could be turned towards 
common psychological addiction 
phenomena, such as affect (guilt, 
dysphoria, depression and anxiety), 
craving (i.e., salience and obsessions) 
and compulsions (i.e., dyscontrol). This 
broader physiological and psychological 
conceptualisation of addiction could 
provide the impetus for the exploration 
of providing non-substance or activity 
specific addiction training (i.e., theory, 
assessment, early intervention and 
treatment) which may also address other 
putative ‘behavioural addictions’, such as 
compulsive sexual behaviour (Schneider 
et al., 2005) and eating disorders (Davis, 
& Calridge, 1998; Gold, Frost-Pineda, 
& Jacobs, 2003; Joranby et al., 2005). 
This is in keeping with the growing 
interest in transdiagnostic approaches 
to psychological interventions. While 
the current paper highlights the common 
clinical features across addictions, a 
transdiagnostic approach to treating 
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these disorders would focus on the 
identification of the shared maintaining 
mechanisms across these addictions and 
co-morbid mood disorders (Egan, Wade 
& Shafran, 2011). It has been suggested 
that both alcohol dependence and 
depression may stem from unsuccessful 
attempts to control unwanted feelings 
and emotions (Petersen & Zettle, 
2009). In support of this, a clinical 
trial of Acceptance and Commitment 
Therapy (ACT) addressing experiential 
avoidance, compared to treatment as 
usual (individual counselling), in those 
with comorbid disorders produced a 
greater therapeutic impact (Petersen 
& Zettle, 2009). This suggests that a 
transdiagnostic treatment approach 
may be useful in SUDS, however, 
a recent paper exploring treatments 
for comorbid mood, anxiety and 
substance use problems noted that 
“little is known about the relative 
benefits of transdiagnostic or integrated 
treatments as compared to single-
disorder interventions” (McHugh & 
Greenfield, 2010. p2). Thus, there is a 
clear need for further research in this 
area.
In conclusion, the acknowledgement 
of CBD as an addiction would provide 
support for increasing research into 
this disorder. Little is known about 
CBD in NZ, a first step to address 
this may be to examine its prevalence 
via screening those attending budget 
advisory services. The Compulsive 
Buying Screen (CBS) is a relatively 
simple and easy measure to administer. 
The importance of addressing online 
compulsive buying is particularly 
relevant in New Zealand at present, with 
the continued development of specific 
online trading, shopping and auction 
sites. It is possible that the burgeoning 
of these online auctions may attract both 
compulsive buyers and pathological 
gambling due to the experiences of 
participants in this study who reported 
that “people get crazy closer to the 
closing of bids and people often pay 
more for the item than when you buy 
them new in the shop”. Maybe this will 
be the addiction of the 22nd century.
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